DETAILED NOTES ON HEMGENIX

Variety of qualified sufferers: CDEC talked about the uncertainty in the quantity of sufferers with moderately serious to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific authorities consulted by CADTH indicated that some sufferers who're classified as having moderate or reasonable condition might have a severe blee